| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9459 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.9127 |
| P-glycoprotein Substrate | Non-substrate | 0.7749 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8914 |
| Non-inhibitor | 0.9499 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8475 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8971 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7297 |
| CYP450 2D6 Substrate | Non-substrate | 0.8420 |
| CYP450 3A4 Substrate | Non-substrate | 0.6973 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.8690 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.6231 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9473 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.8429 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9628 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7255 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9087 |
| Non-inhibitor | 0.8603 |
| AMES Toxicity | Non AMES toxic | 0.9325 |
| Carcinogens | Non-carcinogens | 0.7817 |
| Fish Toxicity | High FHMT | 0.9677 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9884 |
| Honey Bee Toxicity | High HBT | 0.7398 |
| Biodegradation | Not ready biodegradable | 0.7893 |
| Acute Oral Toxicity | III | 0.8400 |
| Carcinogenicity (Three-class) | Non-required | 0.5193 |